Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-07-04 | Xintela | Xintela offentliggör utfall i företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-27 | Xintela | Xintela AB: BioStock: Xintela uppnår milstolpe under förlängd teckningsperiod | Pressreleaser | Visa Stäng |
|
||||
2023-06-22 | Xintela | Xintela completes XSTEM dosing at third and final dose level in knee osteoarthritis clinical study | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-22 | Xintela | Xintela har slutfört doseringen på tredje och sista dosnivån av XSTEM i den kliniska studien för knäartros | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-21 | Xintela | Xintela förlänger teckningsperioden i den pågående företrädesemissionen av units | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-15 | Xintela | Xintelas företrädesemission med units pågår fram till den 19 juni 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-09 | Xintela | Xintela AB: BioStock: Milstolpar i sikte för emissionsaktuella Xintela | Pressreleaser | Visa Stäng |
|
||||
2023-06-09 | Xintela | Xintela publishes positive preclinical results from XSTEM treatment of ARDS | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Xintela publishes positive preclinical results from XSTEM treatment of ARDSResults from Xintela’s preclinical study with XSTEM® for the treatment of ARDS (Acute Respiratory Distress Syndrome) have been published in the journal Respiratory Research. The results show that XSTEM has a therapeutic effect and provides more stable blood circulation, reduced lung tissue damage and reduced blood clotting compared to placebo. Xintela has previously announced that the company’s stem cell product XSTEM was evaluated for the treatment of ARDS in a validated preclinical pig model that is clinically similar to the life-threatening lung complication in ARDS patients. The study, which was partly financed by Vinnova, was carried out in collaboration with Professor Sandra Lindstedt and her team at the Department of Thoracic Surgery, Skåne University Hospital in Lund. The results of this study have now been published in the international scientific journal Respiratory Research ( https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-023-02459-6 ). The results show, among other things, that the animals treated with XSTEM have more stable blood circulation, less lung tissue damage and lower blood coagulation compared to the animals treated with placebo. No negative side effects were noted during the treatment. ARDS is a form of acute severe lung failure that can occur as a result of, for example, pneumonia, sepsis or trauma. With this condition, the lung function collapses and the mortality is high. The is no effective treatment available. “We are really pleased that the results from the study have now been reviewed and published in a very impactful journal. This means that XSTEM will get extra attention as a new treatment option for ARDS with the potential to improve the severe condition in ARDS patients, which can shorten intensive care time and reduce mortality. The results, showing both safety and efficacy, also provide strong support for continued clinical development”, says Xintela’s CEO Evy Lundgren-Åkerlund. |
||||
2023-06-09 | Xintela | Xintela publicerar positiva prekliniska resultat med XSTEM för behandling av ARDS | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-07 | Xintela | Xintela AB: BioStock: Xintelas vd kommenterar emissionen och målen | Pressreleaser | Visa Stäng |
|
||||
2023-06-01 | Xintela | Xintelas kliniska studie med XSTEM för knäartros fortskrider väl | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-01 | Xintela | Xintela's clinical study with XSTEM for knee osteoarthritis makes good progress | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-31 | Xintela | Xintela offentliggör prospekt med anledning av förestående företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Xintela | Xintela AB: BioStock: Xintela highlights the unique properties of XSTEM | Pressreleaser | Visa Stäng |
|
||||
2023-05-30 | Xintela | Xintela AB: BioStock: Xintela lyfter XSTEMs unika egenskaper | Pressreleaser | Visa Stäng |
|
||||
2023-05-25 | Xintela | Xintela AB Delårsrapport januari - mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-25 | Xintela | Xintela AB Interim Report January - March 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Xintela | Xintela genomför företrädesemission av units om cirka 123 MSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-12 | Xintela | Kommuniké från årsstämma i Xintela AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-12 | Xintela | Communiqué from the Annual General Meeting of Xintela AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-02 | Xintela | Xintela AB: BioStock: Xintela inleder sista dosnivån i knäartrosstudie | Pressreleaser | Visa Stäng |
|
||||
2023-05-02 | Xintela | Xintela AB: BioStock: Xintela initiates last dose level in knee osteoarthritis study | Pressreleaser | Visa Stäng |
|
||||
2023-04-28 | Xintela | Xintela AB publishes Annual Report 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-28 | Xintela | Xintela AB publicerar årsredovisning för 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-13 | Xintela | KALLELSE TILL ÅRSSTÄMMA I XINTELA AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-13 | Xintela | Xintela has started last dose level of XSTEM in knee osteoarthritis clinical study | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-13 | Xintela | Xintela har inlett sista dosnivån med XSTEM i klinisk studie för knäartros | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-30 | Xintela | Xintela AB: BioStock Studio:Xintela's chairman about the company's journey | Pressreleaser | Visa Stäng |
|
||||
2023-03-30 | Xintela | Xintela AB: BioStock Studio:Xintelas styrelseordförande om bolagets resa | Pressreleaser | Visa Stäng |
|
||||
2023-03-22 | Xintela | Xintela AB: BioStock: Targinta positions itself in the ADC field | Pressreleaser | Visa Stäng |
|
||||
2023-03-22 | Xintela | Xintela AB: BioStock: Targinta positionerar sig inom ADC-fältet | Pressreleaser | Visa Stäng |
|
||||
2023-03-16 | Xintela | Xintela AB: BioStock Investor Meeting with Xintela | Pressreleaser | Visa Stäng |
|
||||
2023-03-16 | Xintela | Xintela AB: BioStock Investor Meeting med Xintela | Pressreleaser | Visa Stäng |
|
||||
2023-03-03 | Xintela | Xintela completes dosing of XSTEM second dose level in knee osteoarthritis clinical study | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-03 | Xintela | Xintela har genomfört doseringen på andra dosnivån av XSTEM i den kliniska studien för knäartros | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-24 | Xintela | Xintela AB Bokslutskommuniké 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-02-24 | Xintela | Xintela Year-end report 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-02-17 | Xintela | Xintela AB: BioStock: Xintelas vd om strategin för 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-02-17 | Xintela | Xintela AB: BioStock: Xintela's strategy for 2023 | Pressreleaser | Visa Stäng |
|
||||
2022-12-21 | Xintela | Xintela AB: BioStock Studio: Thomas Eldered om Xintelas framsteg | Pressreleaser | Visa Stäng |
|
||||
2022-12-14 | Xintela | Xintela och NorthX Biologics tecknar ramavtal för samarbete | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-14 | Xintela | Xintela and NorthX Biologics sign collaboration framework agreement | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-06 | Xintela | Xintela obtains US patent for stem cell treatment | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-06 | Xintela | Xintela erhåller godkänt patent i USA för stamcellsbehandling | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-28 | Xintela | Kommuniké från extra bolagsstämma i Xintela AB (publ) | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-25 | Xintela | Xintela AB Delårsrapport januari – september 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-25 | Xintela | Xintela AB Interim Report January - September 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-24 | Xintela | Targinta planerar för klinisk fas 0 studie | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-24 | Xintela | Targinta plans Phase 0 clinical study | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-09 | Xintela | Xintela startar nästa dosnivå av XSTEM i klinisk studie för knäartros | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-09 | Xintela | Xintela starts next dose level of XSTEM in knee osteoarthritis clinical study | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-31 | Xintela | Xintela föreslår Thomas Eldered som ny styrelseledamot | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-31 | Xintela | Xintela proposes Thomas Eldered as new Board member | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-26 | Xintela | Kallelse till extra bolagsstämma i Xintela AB (publ) | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-26 | Xintela | Xintela säkrar finansiering om 25 miljoner kronor och beslutar om en riktad emission av konvertibler | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-30 | Xintela | Xintela har genomfört doseringen på första dosnivån av XSTEM i den kliniska studien för knäartros | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-30 | Xintela | Xintela completes dosing of XSTEM first dose level in knee osteoarthritis clinical study | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-22 | Xintela | Targinta utser Peter Ekolind till tillförordnad vd | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-22 | Xintela | Targinta appoints Peter Ekolind as acting CEO | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-20 | Xintela | Xintela starts clinical study with XSTEM for difficult-to-heal leg ulcers | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-20 | Xintela | Xintela startar klinisk studie med XSTEM för svårläkta bensår | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-01 | Xintela | Targinta presenterar positiva prekliniska data för ADC-antikroppen TARG9 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-01 | Xintela | Targinta presents positive preclinical data on the antibody-drug conjugate TARG9 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-31 | Xintela | Uttalande från styrelsen för Xintela med anledning av Flerie Invest AB:s budpliktsbud | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | Xintela | Xintela AB Delårsrapport januari – juni 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | Xintela | Xintela AB Interim Report January - June 2022 | Analyser | Ladda ner | Visa Stäng |
|